BRETT MOORE: Open Payments
NPI 1851362826 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,046 in 83 payments from 15 companies in 2025. Trend: 2023 $2,970 · 2024 $2,721 · 2025 $2,046
Food & beverage: $2,046
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 16 | $417 |
| LEO Pharma Inc. | 18 | $299 |
| ABBVIE INC. | 13 | $237 |
| UCB, Inc. | 4 | $226 |
| GENZYME CORPORATION | 5 | $182 |
| Galderma Laboratories, L.P. | 1 | $119 |
| Lilly USA, LLC | 4 | $112 |
| Regeneron Healthcare Solutions, Inc. | 4 | $109 |
| Arcutis Biotherapeutics, Inc. | 3 | $63 |
| PFIZER INC. | 4 | $62 |
Products named: OPZELURA, DUPIXENT, ADBRY, Bimzelx, RINVOQ, NEMLUVIO, TALTZ, SKYRIZI.
Industry payments across CA — which companies pay providers there.
